The cellular microenvironment regulates CX3CR1 expression on CD8+ T cells and the maintenance of CX3CR1+ CD8+ T cells

被引:1
|
作者
Pokharel, Jyoti [1 ]
Shryki, Iman [1 ]
Zwijnenburg, Anthonie J. [1 ]
Sandu, Ioana [1 ]
Krumm, Laura [1 ]
Bekiari, Christina [1 ]
Avramov, Victor [1 ]
Heinback, Rebecka [1 ]
Lysell, Josefin [2 ]
Eidsmo, Liv [1 ,3 ]
Harris, Helena E. [1 ]
Gerlach, Carmen [1 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Dept Med Solna,Div Rheumatol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Dermatol & Venereol, Stockholm, Sweden
[3] Univ Copenhagen, LEO Fdn Skin Immunol Res Ctr, Copenhagen, Denmark
基金
瑞典研究理事会; 瑞士国家科学基金会;
关键词
CD8 T cell; CX3CL1; CX3CR1; Memory; FRACTALKINE RECEPTOR CX(3)CR1; CHEMOKINE FRACTALKINE; ENDOTHELIAL-CELLS; IFN-GAMMA; TNF-ALPHA; EFFECTOR; DIFFERENTIATION; IDENTIFICATION; CLEAVAGE; BRAIN;
D O I
10.1002/eji.202350658
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Expression levels of the chemokine receptor CX3CR1 serve as high-resolution marker delineating functionally distinct antigen-experienced T-cell states. The factors that influence CX3CR1 expression in T cells are, however, incompletely understood. Here, we show that in vitro priming of naive CD8(+) T cells failed to robustly induce CX3CR1, which highlights the shortcomings of in vitro priming settings in recapitulating in vivo T-cell differentiation. Nevertheless, in vivo generated memory CD8(+) T cells maintained CX3CR1 expression during culture. This allowed us to investigate whether T-cell receptor ligation, cell death, and CX3CL1 binding influence CX3CR1 expression. T-cell receptor stimulation led to downregulation of CX3CR1. Without stimulation, CX3CR1(+) CD8(+) T cells had a selective survival disadvantage, which was enhanced by factors released from necrotic but not apoptotic cells. Exposure to CX3CL1 did not rescue their survival and resulted in a dose-dependent loss of CX3CR1 surface expression. At physiological concentrations of CX3CL1, CX3CR1 surface expression was only minimally reduced, which did not hamper the interpretability of T-cell differentiation states delineated by CX3CR1. Our data further support the broad utility of CX3CR1 surface levels as T-cell differentiation marker and identify factors that influence CX3CR1 expression and the maintenance of CX3CR1 expressing CD8(+) T cells.
引用
收藏
页数:17
相关论文
共 50 条
  • [11] CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy
    Yan, Yiyi
    Cao, Siyu
    Liu, Xin
    Harrington, Susan M.
    Bindeman, Wendy E.
    Adjei, Alex A.
    Jang, Jin Sung
    Jen, Jin
    Li, Ying
    Chanana, Pritha
    Mansfield, Aaron S.
    Park, Sean S.
    Markovic, Svetomir N.
    Dronca, Roxana S.
    Dong, Haidong
    JCI INSIGHT, 2018, 3 (08):
  • [12] Induction of fractalkine and CX3CR1 mediated by host CD8+ T cells in allograft tolerance induced by donor specific blood transfusion
    Louvet, C
    Heslan, JM
    Merieau, E
    Soulillou, JP
    Cuturi, MC
    Chiffoleau, E
    TRANSPLANTATION, 2004, 78 (09) : 1259 - 1266
  • [13] CX3CR1 expression levels define human CD8 T cell subsets
    Zwijnenburg, A.
    Pokharel, J.
    Shryki, I.
    Comet, N. Ramirez
    Zheng, W.
    Eidsmo, L.
    Gerlach, C.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 94 (06)
  • [14] CX3CR1 expression levels define human CD8 T cell subsets
    Zwijnenburg, Anthonie
    Pokharel, Jyoti
    Shryki, Iman
    Comet, Natalia Ramirez
    Zheng, Wenning
    Eidsmo, Liv
    Gerlach, Carmen
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 168 - 168
  • [15] CX3CR1-CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment
    Yamauchi, Takayoshi
    Hoki, Toshifumi
    Oba, Takaaki
    Saito, Hidehito
    Attwood, Kristopher
    Sabel, Michael S.
    Chang, Alfred E.
    Odunsi, Kunle
    Ito, Fumito
    JCI INSIGHT, 2020, 5 (08)
  • [16] CX3CR1+CD8 T cells promote monocyte activation and cardiovascular risk
    Freeman, M.
    Panigrahi, S.
    Mudd, J.
    Sieg, S.
    Funderburg, N.
    Lederman, M.
    Zidar, D.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 76 - 77
  • [17] CD40 Signaling for Generation and Expansion of Cytotoxic CX3CR1+CD8+T Cells
    Yamauchi, T.
    Hoki, T.
    Eppolito, C.
    Francois, A. J.
    Odunsi, K.
    Ito, F.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S175 - S175
  • [18] CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells
    Yamauchi, Takayoshi
    Hoki, Toshifumi
    Oba, Takaaki
    Kajihara, Ryutaro
    Attwood, Kristopher
    Cao, Xuefang
    Ito, Fumito
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (01) : 137 - 151
  • [19] Intratumoral CD8+T-Cell Heterogeneity Defined by the Chemokine Receptor, CX3CR1
    Yamauchi, T.
    Hoki, T.
    Eppolito, C.
    Francois, A. J.
    Odunsi, K.
    Ito, F.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S175 - S175
  • [20] CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells
    Takayoshi Yamauchi
    Toshifumi Hoki
    Takaaki Oba
    Ryutaro Kajihara
    Kristopher Attwood
    Xuefang Cao
    Fumito Ito
    Cancer Immunology, Immunotherapy, 2022, 71 : 137 - 151